Protective Effect of Hesperetin and Naringenin against Apoptosis in Ischemia/Reperfusion-Induced Retinal Injury in Rats
Purpose. Hesperetin and naringenin are naturally common flavonoids reported to have antioxidative effects. This study was performed to investigate whether either hesperetin or naringenin has a protective effect against apoptosis on retinal ischemia/reperfusion (I/R) injury. Methods. Retinal I/R was induced by increasing the intraocular pressure to 150 mmHg for 60 minutes. Thirty-three male Wistar albino rats were randomised into 5 groups named control, I/R + sham, I/R + solvent (DMSO), I/R + hesperetin, and I/R + naringenin. Animals were given either hesperetin, naringenin, or the solvent intraperitoneally immediately following reperfusion. Thickness of retinal layers and retinal cell apoptosis were detected by histological analysis, tunel assay, and immunohistochemistry assay. Results. Hesperetin and naringenin attenuated the I/R-induced apoptosis of retinal cells in the inner and outer nuclear cells of the rat retina. Retinal layer thickness of the naringenin treatment group was significantly thicker than that of the hesperetin, sham, and solvent groups (). Conclusions. Hesperetin and naringenin can prevent harmful effects induced by I/R injury in the rat retina by inhibiting apoptosis of retinal cells, which suggests that those flavanones have a therapeutic potential for the protection of ocular ischemic diseases.
Disruption of the retinal blood supply, called “retinal ischemia,” decreases the delivery of oxygen and essential nutrients to the retina and results in cell death. Restoration of this disrupted retinal circulation is called “reperfusion” and aggravates ischemic injury by several biochemical processes that include oxidative stress, calcium overload caused by glutamate excitotoxicity, inflammation, cellular necrosis, and apoptosis . Many ocular diseases, such as diabetic retinopathy, ischemic optic neuropathy, acute glaucoma, retinal vascular occlusions, and retinopathy of prematurity, are associated with retinal ischemia/reperfusion (I/R) injury . To define and better understand the pathophysiological mechanisms associated with retinal I/R injury, various experimental approaches have been designed using animal models [3, 4]. Simulating transient retinal ischemia by the high intraocular pressure (IOP) model in rats, which is created by transiently elevating the IOP over ocular perfusion pressure, is well recognized and commonly used in experimental studies [2, 5, 6].
Flavonoids are polyphenolic compounds with various pharmacological properties and act as scavengers of free radicals by OH groups in their molecular structure [7, 8]. According to their structural differences, six major classes of flavonoids are present: flavonols, flavones, flavanones, catechins, anthocyanidins, and isoflavones . Hesperetin (3,5,7-trihydroxy-4′-methoxyflavanone) and naringenin (4,5,7-trihydroxyflavanone) are flavanones abundant in citrus fruits, including oranges and grapefruit, as well as tomatoes and cherries . In nature, these flavanones take glycoside form, which enhances intestinal absorption . Several studies have reported that hesperetin and naringenin have anti-inflammatory, antioxidant, anticarcinogenic, and neuroprotective effects [12–15]. Both hesperetin and naringenin are compounds with 3 hydroxyl groups that maintain a greater antioxidant potency and ability to activate cellular antioxidant preventing enzymes than other flavanones [16, 17].
For this study’s purposes, it is important to note that the beneficial effect of hesperetin and naringenin on I/R-induced myocardial, cerebral, renal, and pancreatic injury has been demonstrated [18–21]. However, to the best of our knowledge, no study has yet evaluated apoptosis and structural damage on retinal I/R injury. Thus, we aimed to evaluate the possible protective effects of naringenin and hesperetin on retinal I/R injury model in rats.
2. Material and Method
Thirty-three healthy male Wistar albino rats weighing 250–300 g were obtained from Saki Yenilli Animal Laboratory, Ankara, Turkey. The animals were housed for a 12-h light/12-h dark cycle. Animal experiments were conducted in accordance with the Statement on the Use of Animals of the Association for Research in Vision and Ophthalmology. The institutional review board of the University of Canakkale Onsekiz Mart, Turkey, approved the research.
2.2. Ischemia and Reperfusion
Rats were anesthetised with intramuscular ketamine chloride (80 mg/kg: Ketalar, Eczacıbaşı, Istanbul, Turkey) and xylazine (4 mg/kg: Rompun, Bayer, Istanbul, Turkey). Corneal analgesia was achieved by using a topical application of 0.5% proparacaine hydrochloride (0.5% Alcaine; Alcon, USA). To preserve body temperature of the rats, they were placed in containers to cover their body. The anterior chamber of the right eye was cannulated with a 30-gauge infusion needle connected to a saline bottle. Retinal acute ischemia was induced by elevating the bottle to a height of 2 m to maintain an intraocular pressure of 150 mmHg for 60 minutes. Retinal ischemia was confirmed by the loss of red reflex and its return just after reperfusion. After a 60-minute period of ischemia, the IOP was returned to its normal values by removing the infusion cannula. Ofloxacin (0.3%) was applied topically to the eye to prevent infection. The rats in the control group were administered by cannulating a 30-gauge needle into the anterior chamber without elevating IOP.
2.3. Drug Administration
Hesperetin (20 mg/kg, Sigma-Aldrich Chemical Co., United Kingdom) and naringenin (20 mg/kg, Sigma-Aldrich Chemical Co., United Kingdom) were freshly prepared by dissolving the powder in dimethyl sulfoxide (DMSO) for intraperitoneal administration. The rats were randomly assigned to five groups: control (), I/R + sham (), I/R + solvent (DMSO) (), I/R + hesperetin (), and I/R + naringenin (). Animals were given either drug (hesperetin or naringenin) or DMSO intraperitoneally immediately following reperfusion.
2.4. Tissue Collection and Histological Analysis
The rats were anesthetised by intraperitoneal administration of 80 mg/kg ketamine and 4 mg/kg xylazine, 48 hours after retinal I/R injury. Eyes tissue samples were obtained for histopathological and immunochemistry investigation. Eyes samples fixed with 10% formaldehyde solution for 48 hours, embedded in paraffin. Sections 5-μm thick were obtained using a microtome (Leica, RM2245) and stained with haematoxylin and eosin (H&E). Retinal thickness was quantified in three separate positions: central (100–150 μm from the optic nerve), peripheral (100–150 μm from the ora serrata), and midperipheral (halfway between the central and peripheral). Two representative sections were selected from the same three positions randomly for each eye, from which measurements were taken and their values averaged .
2.5. Immunohistochemistry in the Retina
The eye samples were fixed in 10% formaldehyde solution and embedded in paraffin. Immunohistochemical reactions were performed according to the avidin biotin-peroxidase complex technique described by Hsu et al. . Five μm-thick sections were obtained, and the slides were air-dried and the tissue deparaffinised. Slides were washed in 0.01 mol/L phosphate-buffered saline (PBS). After washes with PBS, an antigen retrieval solution (0.01 M citrate buffer, pH 6.0) was applied for 10 minutes at 100°C in a microwave oven, and endogenous peroxidase was eliminated by incubation in 3% in pH 7.4 in PBS (0.01 M) for 10 minutes. After washing, specimens were treated with a blocking serum (Labvision, TR-060-UB) at room temperature for 10 minutes. The sections were incubated with rabbit polyclonal anti-Caspase 3 (Abcam, ab4051; dilution 1 : 100) and reacted with tissue specimens at room temperature for 90 minutes. Sections were then washed three times with PBS and incubated with biotinylated secondary antibody (Ultra Vision Detection System-HRP kit, Thermo, Fremont, California, USA). Streptavidin peroxidase (Ultra Vision Detection System-HRP kit, Lab Vision, Fremont, California, USA) was given at room temperature for 20 minutes. 3,3′-Diaminobenzidine (DAB) was used as a chromogen, and sections were counterstained with haematoxylin.
2.6. Tunel Assay
Apoptotic cells were visualized by using a terminal deoxynucleotidyl transferase dUTP nick-end labeling (tunel) assay kit (TdT-Fragel TM DNA Fragmentation Detection Kit, Cat. no. QIA33, Calbiochem, USA). In brief, paraffin sections were deparaffinised in the xylene for 3 × 5 minutes, washing with absolute ethanol (2 × 5 minutes), washing once with 95% ethanol and once with 70% ethanol, and after that washing by applying 20 mg/mL proteinase K (20 min.). Endogenous peroxidase activity was inhibited by incubation with 3% hydrogen peroxide. Sections were incubated with an equilibration buffer for 10 to 30 minutes and then with TdT-enzyme, in a humidified atmosphere at 37°C, for 60 minutes. They were subsequently put into prewarmed working strength stop/wash buffer at room temperature for 10 minutes and incubated with a blocking buffer for 30 minutes. Each step was separated by thorough washes in tris-buffered saline (TBS). Labeling was revealed using DAB, counter staining was performed using haematoxylin, and sections were dehydrated, cleared, and mounted .
2.7. Statistical Analysis
The data were expressed as mean ± standard deviation (SE). Differences among the groups were evaluated using one-way analysis of variance (ANOVA). The Bartlett test was used to determine whether the data were heterogeneous or homogeneous. The Bonferroni multiple comparison procedure was then applied to identify differences between means. Differences were considered significant at .
Excepting the naringenin treatment group, 48 hours after retinal I/R injury the overall retinal thickness and other layers of the retina were significantly decreased compared to the control group (, Table 1, Figures 1(a) and 1(b)). It is shown that hesperetin and naringenin treatment groups have thicker inner retinal layers when compared to sham and solvent groups (, Table 1, Figures 1(b), 1(c), 1(d), and 1(e)). It is also shown that the retinal thickness of the naringenin treatment group was significantly more improved than the hesperetin group (, Table 1). In the naringenin treatment group, there was not statistically significant difference in the retinal thickness when compared with the control group.
The effects of I/R on retinal cell death were examined by measuring caspase-3 level and DNA fragmentation in nucleus. Tunel staining was used to detect DNA fragmentation of cells undergoing apoptosis. In the control group, the retina cell nuclei were almost negative for tunel staining (Table 2, Figure 2(a)). Significantly more tunel-positive cells were found within the inner nuclear cells in the sham and solvent groups than in the control group (, Table 2, Figures 2(b) and 2(c)). By contrast, in rats subjected to I/R with hesperetin or naringenin treatment, significantly less tunel-positive cells were found compared to the other groups (, Table 2, Figures 2(d) and 2(e)). It was also demonstrated that the naringenin treatment group has fewer tunel-positive cells than the hesperetin group (). We performed immunohistochemistry to detect activated caspase-3. The number of caspase-3 positive cells was significantly less in the retina of rats treated with hesperetin or naringenin than in the retina of the sham and solvent groups, which had retinal damage induced by I/R (, Table 3, Figure 3).
This study evaluated the probable protective effects of the two flavanones (hesperetin and naringenin) on the retinal damage caused by I/R in a rat retinal model by studying retinal morphology and immunohistochemistry. The retinal thickness and the quantity of apoptotic cells were compared between I/R groups and the control group. It was found that naringenin and hesperetin markedly reduced retinal cell injury following I/R in comparison to the sham and solvent groups. In addition, we also found that the treatment of naringenin inhibited the apoptosis of the retinal cells and reduced the thinning of the retinal thickness more effectively when compared to hesperetin.
Flavonoids and diets rich with flavonoids have been reported to maintain treatment for several diseases with their powerful antioxidant activity, which also modulates the enzymatic activity [25, 26]. Antioxidant activity of the flavonoids favors by the presence of a 3-hydroxyl group in the heterocyclic ring and a catechol group in ring B, which are also the structural features of hesperetin and naringenin [16, 27]. Although this study implemented a treatment method of intraperitoneal injection of flavonoids, their intestinal absorbable forms include a 2-hydroxyl group (hesperidin and naringin), which appears in citrus fruits naturally and are converted to biologically active forms (hesperetin and naringenin) in vivo [16, 28]. As those have 3-hydroxyl group, hesperetin and naringenin have been suggested to be more effective antioxidants than ascorbic acid and α-tocopherol, particularly for urgent antioxidative treatment needs . Flavonoids also have potency to increase ocular blood flow in relation to the quantity of OH groups. Xu et al.  showed that intraperitoneal injection of hesperetin and naringenin increased ocular blood flow; thus, the retinal function recovery was facilitated during retinal I/R insult. It was suggested that flavonoids improve endothelium-dependent (enhance NO bioavailability) and endothelium-independent (inhibit the responses to ) vasodilatation after I/R, as well as protect vascular function . Our findings are demonstrating the prevention of structural damage and apoptosis in a retinal I/R injury animal model with the use of naringenin and hesperetin treatments that are compatible with the prior studies.
The neuroprotective effect of flavanones on cerebral I/R injury was shown in recent studies [12, 31–33]. Shi et al.  demonstrated that pinocembrin (5,7-dihydroxy flavanone) significantly reduced neuronal loss and brain edema at 24 h after global cerebral I/R with a broad therapeutic time window (intravenously 30 min before ischemia and 30 min, 2 h, and 6 h after reperfusion). Flavonoids seem to sufficiently affect the ischemic site of the neuronal cells when the drug is applied just after I/R. We also aimed to investigate the therapeutic potential of hesperetin and naringenin after I/R because occlusive retinal diseases are nonpredictable. Hesperetin and naringenin were reported to exhibit protective effects in oxidative stress associated neurodegeneration [12, 32, 33]. In addition, Hwang et al.  revealed a novel mechanism that hesperetin triggers estrogen receptor (ER)- and TrkA-mediated parallel pathways which induces neuroprotective effect.
This study shows that retinal cell injury seems to occur 2 days after I/R, as demonstrated with the sham group . It is commonly accepted that I/R is associated with increased oxygen-radical production; other factors including excitatory amino acids, and reduced vasodilator reserve leading to retinal cell damage [35–37]. Earlier studies have shown that apoptosis and necrosis are parts of I/R-induced retinal cell damage [1, 38]. There are various apoptotic proteins in apoptotic cell death, including caspase family members. Caspase-3 particularly is a key enzyme required for execution of apoptosis . In the present study, we have seen an increased amount of cells with caspase-3 compared to normal retina. Treatment with hesperetin or naringenin similarly reduced caspase-3 positive cells as compared to the sham and solvent groups. In our tunel study, a significant number of tunel-positive cells were found after I/R. However, the affected cell amount markedly decreased with hesperetin and naringenin treatment immediately after the ischemic period. Consistent with Chiou and Xu , this study has shown that naringenin is more protective for retinal cells during the reperfusion period. There were less tunel-positive or caspase-3-positive cells in the ONL than the INL. It was suggested that free radicals penetrate slowly to the outer segment of the retina and so photoreceptor cells are affected at last .
An important limitation in this study is that only one dose of both hesperetin and naringenin was studied. Therefore, further studies are needed to evaluate the protective effect of these drugs in different doses. In addition, the current study did not examine the mechanism of the neuroprotective effects of hesperetin and naringenin.
In conclusion, this study is important as it is the first to clearly show the protective role of three-hydroxyl-inclusive flavanones (hesperetin and naringenin) during retinal apoptosis and morphology with the retinal I/R injury in rats. Further investigations are necessary to evaluate the therapeutic potential and mechanism of hesperetin and naringenin for the prevention of ocular ischemic diseases.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
E. R. Büchi, “Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer,” Experimental Eye Research, vol. 55, no. 4, pp. 605–613, 1992.View at: Publisher Site | Google Scholar
N. N. Osborne, R. J. Casson, J. P. M. Wood, G. Chidlow, M. Graham, and J. Melena, “Retinal ischemia: mechanisms of damage and potential therapeutic strategies,” Progress in Retinal and Eye Research, vol. 23, no. 1, pp. 91–147, 2004.View at: Publisher Site | Google Scholar
C. Harada, T. Harada, B. S. Slusher, K. Yoshida, H. Matsuda, and K. Wada, “N-acetylated-α-linked-acidic dipeptidase inhibitor has a neuroprotective effect on mouse retinal ganglion cells after pressure-induced ischemia,” Neuroscience Letters, vol. 292, no. 2, pp. 134–136, 2000.View at: Publisher Site | Google Scholar
H. Ogishima, S. Nakamura, T. Nakanishi et al., “Ligation of the pterygopalatine and external carotid arteries induces ischemic damage in the murine retina,” Investigative Ophthalmology & Visual Science, vol. 52, no. 13, pp. 9710–9720, 2011.View at: Google Scholar
E. R. Büchi, I. Suivaizdis, and J. Fu, “Pressure-induced retinal ischemia in rats: an experimental model for quantitative study,” Ophthalmologica, vol. 203, no. 3, pp. 138–147, 1991.View at: Google Scholar
U. Yiğit, S. Erdenöz, U. Uslu et al., “An immunohistochemical analysis of the neuroprotective effects of memantine, hyperbaric oxygen therapy, and brimonidine after acute ischemia reperfusion injury,” Molecular Vision, vol. 17, pp. 1024–1033, 2011.View at: Google Scholar
D. Arul and P. Subramanian, “Inhibitory effect of naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats,” Biochemical and Biophysical Research Communications, vol. 434, pp. 203–209, 2013.View at: Google Scholar
S. Keser, S. Celik, and S. Turkoglu, “Total phenolic contents and free-radical scavenging activities of grape (Vitis vinifera L.) and grape products,” International Journal of Food Sciences and Nutrition, vol. 64, pp. 210–216, 2013.View at: Google Scholar
T. Kinoshita, Z. Lepp, Y. Kawai, J. Terao, and H. Chuman, “An integrated database of flavonoids,” BioFactors, vol. 26, no. 3, pp. 179–188, 2006.View at: Google Scholar
S. Kawaii, Y. Tomono, E. Katase, K. Ogawa, and M. Yano, “Quantitation of flavonoid constituents in Citrus fruits,” Journal of Agricultural and Food Chemistry, vol. 47, no. 9, pp. 3565–3571, 1999.View at: Publisher Site | Google Scholar
F. Haidari, S. A. Keshavarz, M. R. Rashidi, and M. M. Shahi, “Orange juice and hesperetin supplementation to hyperuricemic rats alter oxidative stress markers and xanthine oxidoreductase activity,” Journal of Clinical Biochemistry and Nutrition, vol. 45, no. 3, pp. 285–291, 2009.View at: Publisher Site | Google Scholar
E. J. Choi and W. S. Ahn, “Neuroprotective effects of chronic hesperetin administration in mice,” Archives of Pharmacal Research, vol. 31, no. 11, pp. 1457–1462, 2008.View at: Publisher Site | Google Scholar
N. Nalini, S. Aranganathan, and J. Kabalimurthy, “Chemopreventive efficacy of hesperetin (citrus flavonone) against 1, 2-dimethylhydrazine-induced rat colon carcinogenesis,” Toxicology Mechanisms and Methods, vol. 22, pp. 397–408, 2012.View at: Google Scholar
J. Lee and G. Kim, “Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis,” Journal of Food Science, vol. 75, no. 7, pp. H212–H217, 2010.View at: Publisher Site | Google Scholar
Y. Miyake, K. Minato, S. Fukumoto et al., “New potent antioxidative hydroxyflavanones produced with Aspergillus saitoi from flavanone glycoside in citrus fruit,” Bioscience, Biotechnology and Biochemistry, vol. 67, no. 7, pp. 1443–1450, 2003.View at: Google Scholar
G. C. Y. Chiou and X. Xu, “Effects of some natural flavonoids on retinal function recovery after ischemic insult in the rat,” Journal of Ocular Pharmacology and Therapeutics, vol. 20, no. 2, pp. 107–113, 2004.View at: Publisher Site | Google Scholar
S. E. Pollard, M. Whiteman, and J. P. E. Spencer, “Modulation of peroxynitrite-induced fibroblast injury by hesperetin: a role for intracellular scavenging and modulation of ERK signalling,” Biochemical and Biophysical Research Communications, vol. 347, no. 4, pp. 916–923, 2006.View at: Publisher Site | Google Scholar
L. Testai, A. Martelli, M. Cristofaro, M. C. Breschi, and V. Calderone, “Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts,” Journal of Pharmacology and Pharmacotherapeutics, vol. 65, pp. 750–756, 2013.View at: Google Scholar
S. S. Raza, M. M. Khan, A. Ahmad et al., “Neuroprotective effect of naringenin is mediated through suppression of NF-κB signaling pathway in experimental stroke,” Neuroscience, vol. 230, pp. 157–171, 2013.View at: Google Scholar
T. Ahlenstiel, G. Burkhardt, H. Köhler, and M. K. Kuhlmann, “Improved cold preservation of kidney tubular cells by means of adding bioflavonoids to organ preservation solutions,” Transplantation, vol. 81, no. 2, pp. 231–239, 2006.View at: Publisher Site | Google Scholar
A. Dembinski, Z. Warzecha, S. J. Konturek et al., “Extract of grapefruit-seed reduces acute pancreatitis induced by ischemia/reperfusion in rats; possible implication of tissue antioxidants,” Journal of Physiology and Pharmacology, vol. 55, no. 4, pp. 811–821, 2004.View at: Google Scholar
T. T. Woo, S. Y. Li, W. W. Lai, D. Wong, and A. C. Lo, “Neuroprotective effects of lutein in a rat model of retinal detachment,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 251, pp. 41–51, 2013.View at: Google Scholar
S. M. Hsu, L. Raine, and H. Fanger, “Use of Avidin-Biotin-Peroxidase Complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures,” Journal of Histochemistry and Cytochemistry, vol. 29, no. 4, pp. 577–580, 1981.View at: Google Scholar
S. Oguz, M. Kanter, M. Erboga, and C. Ibis, “Protective effect of Urtica dioica on liver damage induced by biliary obstruction in rats,” Toxicology and Industrial Health, vol. 29, no. 9, pp. 838–845, 2012.View at: Publisher Site | Google Scholar
S. Aranganathan and N. Nalini, “Efficacy of the potential chemopreventive agent, hesperetin (citrus flavanone), on 1,2-dimethylhydrazine induced colon carcinogenesis,” Food and Chemical Toxicology, vol. 47, no. 10, pp. 2594–2600, 2009.View at: Publisher Site | Google Scholar
Y. J. Moon, X. Wang, and M. E. Morris, “Dietary flavonoids: effects on xenobiotic and carcinogen metabolism,” Toxicology in Vitro, vol. 20, no. 2, pp. 187–210, 2006.View at: Publisher Site | Google Scholar
P. Pietta, “Flavonoids as antioxidants,” Journal of Natural Products, vol. 63, no. 7, pp. 1035–1042, 2000.View at: Publisher Site | Google Scholar
A. F. Furtado, M. A. Nunes, and M. H. Ribeiro, “Hesperidinase encapsulation towards hesperitin production targeting improved bioavailability,” Journal of Molecular Recognition, vol. 25, pp. 595–603, 2012.View at: Google Scholar
O. L. Woodman and E. C. H. Chan, “Vascular and anti-oxidant actions of flavonols and flavones,” Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 11, pp. 786–790, 2004.View at: Publisher Site | Google Scholar
X. Xu, Y. Park, and G. C. Y. Chiou, “Effects of dihydrogenation of flavones and number of hydroxy groups in the molecules on ocular blood flow in rabbits and retinal function recovery in rats,” Journal of Ocular Pharmacology and Therapeutics, vol. 20, no. 4, pp. 311–320, 2004.View at: Publisher Site | Google Scholar
L. Shi, B. Chen, M. Gao et al., “The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats,” Life Sciences, vol. 88, no. 11-12, pp. 521–528, 2011.View at: Publisher Site | Google Scholar
S. L. Hwang, J. A. Lin, P. H. Shih, C. T. Yeh, and G. C. Yen, “Pro-cellular survival and neuroprotection of citrus flavonoid: the actions of hesperetin in PC12 cells,” Food and Function, vol. 3, pp. 1082–1090, 2012.View at: Google Scholar
H. J. Heo, D. Kim, S. C. Shin, M. J. Kim, B. G. Kim, and D. Shin, “Effect of antioxidant flavanone, naringenin, from Citrus junoson neuroprotection,” Journal of Agricultural and Food Chemistry, vol. 52, no. 6, pp. 1520–1525, 2004.View at: Publisher Site | Google Scholar
S. F. Abcouwer, C. Lin, E. B. Wolpert et al., “Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury,” Investigative Ophthalmology and Visual Science, vol. 51, no. 11, pp. 5920–5933, 2010.View at: Publisher Site | Google Scholar
J. L. Zweier, “Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury,” The Journal of Biological Chemistry, vol. 263, no. 3, pp. 1353–1357, 1988.View at: Google Scholar
D. J. Hearse, L. Maxwell, C. Saldanha, and J. B. Gavin, “The myocardial vasculature during ischemia and reperfusion: a target for injury and protection,” Journal of Molecular and Cellular Cardiology, vol. 25, no. 7, pp. 759–800, 1993.View at: Publisher Site | Google Scholar
I. L. Ferreira, C. B. Duarte, and A. P. Carvalho, “Ca2+ influx through glutamate receptor-associated channels in retina cells correlates with neuronal cell death,” European Journal of Pharmacology, vol. 302, no. 1–3, pp. 153–162, 1996.View at: Publisher Site | Google Scholar
L. A. Levin and A. Louhab, “Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy,” Archives of Ophthalmology, vol. 114, no. 4, pp. 488–491, 1996.View at: Google Scholar
F. Doonan and T. G. Cotter, “Apoptosis: a potential therapeutic target for retinal degenerations,” Current Neurovascular Research, vol. 1, no. 1, pp. 41–53, 2004, Erratum in: Current Neurovascular Research, vol. 1, article 191, 2004.View at: Google Scholar
W. Ju, K. Kim, H. Hofmann et al., “Selective neuronal survival and upregulation of PCNA in the rat inner retina following transient ischemia,” Journal of Neuropathology and Experimental Neurology, vol. 59, no. 3, pp. 241–250, 2000.View at: Google Scholar